InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Goldstein Michael H., Président, Ophtalmologie et Directeur Médical. Insider active across 2 companies, notably OCULAR THERAPEUTIX, INC. Cumulatively, 1 reports have been logged. History available since 3 February 2022. The latest transaction was filed on 3 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Michael H. Goldstein is the President of Ophthalmology and Chief Medical Officer at Ocular Therapeutix, Inc. He oversees the company's clinical and research initiatives. With expertise in the healthcare sector, he plays a key role in developing new therapies and improving patient care.